More reads

• We may not have to age so fast. (Wall Street Journal)
• Gilead's filgotinib fails midphase tests in lupus, Sjogren's. (FierceBiotech)
• Verseon faces painful reversal after Woodford biotech bubble bursts. (Financial Times)
• German university finds 'severe misconduct' by researcher who promoted questionable blood cancer test. (Science)